{"id":232875,"date":"2025-12-29T12:07:22","date_gmt":"2025-12-29T11:07:22","guid":{"rendered":"https:\/\/www.echosens.com\/clinical-utility-vcte-alpha-1-antitrypsin-deficiency\/"},"modified":"2026-01-15T14:20:38","modified_gmt":"2026-01-15T13:20:38","slug":"utilidad-clinica-vcte-alfa-1-antitripsina","status":"publish","type":"page","link":"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/","title":{"rendered":"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":13,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/modular.php","meta":{"_acf_changed":false,"_searchwp_excluded":"","footnotes":""},"class_list":["post-232875","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina - Echosens<\/title>\n<meta name=\"description\" content=\"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina - Echosens\" \/>\n<meta property=\"og:description\" content=\"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/\" \/>\n<meta property=\"og:site_name\" content=\"Echosens\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fibroscan.echosens\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-15T13:20:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Echosens\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/\",\"url\":\"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/\",\"name\":\"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina - Echosens\",\"isPartOf\":{\"@id\":\"https:\/\/www.echosens.com\/es\/#website\"},\"datePublished\":\"2025-12-29T11:07:22+00:00\",\"dateModified\":\"2026-01-15T13:20:38+00:00\",\"description\":\"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina\",\"breadcrumb\":{\"@id\":\"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.echosens.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.echosens.com\/es\/#website\",\"url\":\"https:\/\/www.echosens.com\/es\/\",\"name\":\"Echosens\",\"description\":\"Un site utilisant WordPress\",\"publisher\":{\"@id\":\"https:\/\/www.echosens.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.echosens.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.echosens.com\/es\/#organization\",\"name\":\"ECHOSENS\",\"url\":\"https:\/\/www.echosens.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.echosens.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg\",\"contentUrl\":\"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ECHOSENS\"},\"image\":{\"@id\":\"https:\/\/www.echosens.com\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/fibroscan.echosens\",\"https:\/\/x.com\/Echosens\",\"https:\/\/www.linkedin.com\/company\/echosens\/\",\"https:\/\/www.youtube.com\/channel\/UC1myqoq18t1dKPTz0u1eEgg\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina - Echosens","description":"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/","og_locale":"es_ES","og_type":"article","og_title":"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina - Echosens","og_description":"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina","og_url":"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/","og_site_name":"Echosens","article_publisher":"https:\/\/www.facebook.com\/fibroscan.echosens","article_modified_time":"2026-01-15T13:20:38+00:00","twitter_card":"summary_large_image","twitter_site":"@Echosens","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/","url":"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/","name":"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina - Echosens","isPartOf":{"@id":"https:\/\/www.echosens.com\/es\/#website"},"datePublished":"2025-12-29T11:07:22+00:00","dateModified":"2026-01-15T13:20:38+00:00","description":"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina","breadcrumb":{"@id":"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.echosens.com\/es\/utilidad-clinica-vcte-alfa-1-antitripsina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.echosens.com\/es\/"},{"@type":"ListItem","position":2,"name":"Utilidad cl\u00ednica de la VCTE para la fibrosis hep\u00e1tica en personas con deficiencia de alfa-1 antitripsina"}]},{"@type":"WebSite","@id":"https:\/\/www.echosens.com\/es\/#website","url":"https:\/\/www.echosens.com\/es\/","name":"Echosens","description":"Un site utilisant WordPress","publisher":{"@id":"https:\/\/www.echosens.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.echosens.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.echosens.com\/es\/#organization","name":"ECHOSENS","url":"https:\/\/www.echosens.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.echosens.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","contentUrl":"https:\/\/www.echosens.com\/wp-content\/uploads\/2020\/12\/logo.svg","width":1,"height":1,"caption":"ECHOSENS"},"image":{"@id":"https:\/\/www.echosens.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/fibroscan.echosens","https:\/\/x.com\/Echosens","https:\/\/www.linkedin.com\/company\/echosens\/","https:\/\/www.youtube.com\/channel\/UC1myqoq18t1dKPTz0u1eEgg"]}]}},"_links":{"self":[{"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/pages\/232875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/comments?post=232875"}],"version-history":[{"count":9,"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/pages\/232875\/revisions"}],"predecessor-version":[{"id":287809,"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/pages\/232875\/revisions\/287809"}],"wp:attachment":[{"href":"https:\/\/www.echosens.com\/es\/wp-json\/wp\/v2\/media?parent=232875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}